Biosafety

The University of Cincinnati Biosafety Office is responsible for performing risk assessments to identify hazards and to guide researchers in implementing safety practices and procedures to minimize or eliminate risks associated with research involving biohazardous or potentially biohazardous materials.

All Forms, Policies and Procedures are now located within Research How 2, where faculty and staff will find a centralized location for all their transactional needs.

Welcome to the University of Cincinnati’s Biosafety Office. We are committed to provide safety guidance to the research community and ensure that all are compliant with institutional requirements and federal, state and local regulations pertaining to the possession, use and transfer of biohazardous materials.

The Biosafety Office provides administrative support to the Institutional Biosafety Committee (IBC) which is charged with reviewing and approving all University research activities involving the use of biohazardous materials and recombinant or synthetic nucleic acid molecules, as described in the National Institutes for Health “Guidelines for Research Involving the Use of Recombinant or Synthetic Nucleic Acid Molecules” (NIH Guidelines) and the current edition of the Centers for Disease Control and Prevention’s “Biohazards in Microbiological and Biomedical Laboratories” (the “BMBL” or CDC Guidelines). The Biosafety Office and IBC work closely to ensure the safety and health of research staff and compliance with the applicable laws.

Watch this short VIDEO to learn what the Biosafety Office can do for you.

IBC protocol DATABASE (quick link)